Global Biothrax (Anthrax Vaccine) Market Research Report 2024, Forecast to 2032
Report Overview
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax. Biothrax, commonly known as the anthrax vaccine, is a medical countermeasure developed to protect individuals from anthrax, a potentially lethal bacterial infection caused by Bacillus anthracis. The vaccine is used primarily for military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. It stimulates the immune system to produce antibodies against the anthrax toxin, preventing the progression of the disease if exposed to the bacteria. Biothrax is administered through a series of doses and boosters and is a critical component of preparedness against bioterrorism threats involving anthrax.
The global Biothrax (Anthrax Vaccine) market size was estimated at USD 655 million in 2023 and is projected to reach USD 1276.98 million by 2032, exhibiting a CAGR of 7.70% during the forecast period.
North America Biothrax (Anthrax Vaccine) market size was estimated at USD 193.95 million in 2023, at a CAGR of 6.60% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Biothrax (Anthrax Vaccine) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biothrax (Anthrax Vaccine) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biothrax (Anthrax Vaccine) market in any manner.
Global Biothrax (Anthrax Vaccine) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogйnesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santй Animale
Intervac
JOVAC
Market Segmentation (by Type)
Live Vaccines
Cell Free PA Vaccines
Market Segmentation (by Application)
Human Use
Animal Use
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biothrax (Anthrax Vaccine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biothrax (Anthrax Vaccine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax. Biothrax, commonly known as the anthrax vaccine, is a medical countermeasure developed to protect individuals from anthrax, a potentially lethal bacterial infection caused by Bacillus anthracis. The vaccine is used primarily for military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. It stimulates the immune system to produce antibodies against the anthrax toxin, preventing the progression of the disease if exposed to the bacteria. Biothrax is administered through a series of doses and boosters and is a critical component of preparedness against bioterrorism threats involving anthrax.
The global Biothrax (Anthrax Vaccine) market size was estimated at USD 655 million in 2023 and is projected to reach USD 1276.98 million by 2032, exhibiting a CAGR of 7.70% during the forecast period.
North America Biothrax (Anthrax Vaccine) market size was estimated at USD 193.95 million in 2023, at a CAGR of 6.60% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Biothrax (Anthrax Vaccine) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biothrax (Anthrax Vaccine) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biothrax (Anthrax Vaccine) market in any manner.
Global Biothrax (Anthrax Vaccine) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogйnesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santй Animale
Intervac
JOVAC
Market Segmentation (by Type)
Live Vaccines
Cell Free PA Vaccines
Market Segmentation (by Application)
Human Use
Animal Use
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biothrax (Anthrax Vaccine) Market
- Overview of the regional outlook of the Biothrax (Anthrax Vaccine) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biothrax (Anthrax Vaccine) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biothrax (Anthrax Vaccine), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biothrax (Anthrax Vaccine)
1.2 Key Market Segments
1.2.1 Biothrax (Anthrax Vaccine) Segment by Type
1.2.2 Biothrax (Anthrax Vaccine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTHRAX (ANTHRAX VACCINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTHRAX (ANTHRAX VACCINE) MARKET COMPETITIVE LANDSCAPE
3.1 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (2019-2024)
3.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2019-2024)
3.3 Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biothrax (Anthrax Vaccine) Sales Sites, Area Served, Product Type
3.6 Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
3.6.1 Biothrax (Anthrax Vaccine) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOTHRAX (ANTHRAX VACCINE) INDUSTRY CHAIN ANALYSIS
4.1 Biothrax (Anthrax Vaccine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTHRAX (ANTHRAX VACCINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2019-2024)
6.3 Global Biothrax (Anthrax Vaccine) Market Size Market Share by Type (2019-2024)
6.4 Global Biothrax (Anthrax Vaccine) Price by Type (2019-2024)
7 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biothrax (Anthrax Vaccine) Market Sales by Application (2019-2024)
7.3 Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Application (2019-2024)
7.4 Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2019-2024)
8 BIOTHRAX (ANTHRAX VACCINE) MARKET CONSUMPTION BY REGION
8.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Region
8.2 North America
8.2.1 North America Biothrax (Anthrax Vaccine) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biothrax (Anthrax Vaccine) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biothrax (Anthrax Vaccine) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 BIOTHRAX (ANTHRAX VACCINE) MARKET PRODUCTION BY REGION
9.1 Global Production of Biothrax (Anthrax Vaccine) by Region (2019-2024)
9.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2019-2024)
9.3 Global Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Biothrax (Anthrax Vaccine) Production
9.4.1 North America Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.4.2 North America Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Biothrax (Anthrax Vaccine) Production
9.5.1 Europe Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.5.2 Europe Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Biothrax (Anthrax Vaccine) Production (2019-2024)
9.6.1 Japan Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.6.2 Japan Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Biothrax (Anthrax Vaccine) Production (2019-2024)
9.7.1 China Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.7.2 China Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Merial
10.1.1 Merial Biothrax (Anthrax Vaccine) Basic Information
10.1.2 Merial Biothrax (Anthrax Vaccine) Product Overview
10.1.3 Merial Biothrax (Anthrax Vaccine) Product Market Performance
10.1.4 Merial Business Overview
10.1.5 Merial Biothrax (Anthrax Vaccine) SWOT Analysis
10.1.6 Merial Recent Developments
10.2 Merck
10.2.1 Merck Biothrax (Anthrax Vaccine) Basic Information
10.2.2 Merck Biothrax (Anthrax Vaccine) Product Overview
10.2.3 Merck Biothrax (Anthrax Vaccine) Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck Biothrax (Anthrax Vaccine) SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Zoetis
10.3.1 Zoetis Biothrax (Anthrax Vaccine) Basic Information
10.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Overview
10.3.3 Zoetis Biothrax (Anthrax Vaccine) Product Market Performance
10.3.4 Zoetis Biothrax (Anthrax Vaccine) SWOT Analysis
10.3.5 Zoetis Business Overview
10.3.6 Zoetis Recent Developments
10.4 Bayer Sanidad Animal
10.4.1 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Basic Information
10.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
10.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Market Performance
10.4.4 Bayer Sanidad Animal Business Overview
10.4.5 Bayer Sanidad Animal Recent Developments
10.5 Colorado Serum
10.5.1 Colorado Serum Biothrax (Anthrax Vaccine) Basic Information
10.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
10.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Product Market Performance
10.5.4 Colorado Serum Business Overview
10.5.5 Colorado Serum Recent Developments
10.6 PharmAthene
10.6.1 PharmAthene Biothrax (Anthrax Vaccine) Basic Information
10.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Overview
10.6.3 PharmAthene Biothrax (Anthrax Vaccine) Product Market Performance
10.6.4 PharmAthene Business Overview
10.6.5 PharmAthene Recent Developments
10.7 Tiankang
10.7.1 Tiankang Biothrax (Anthrax Vaccine) Basic Information
10.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Overview
10.7.3 Tiankang Biothrax (Anthrax Vaccine) Product Market Performance
10.7.4 Tiankang Business Overview
10.7.5 Tiankang Recent Developments
10.8 Biogйnesis-Bago
10.8.1 Biogйnesis-Bago Biothrax (Anthrax Vaccine) Basic Information
10.8.2 Biogйnesis-Bago Biothrax (Anthrax Vaccine) Product Overview
10.8.3 Biogйnesis-Bago Biothrax (Anthrax Vaccine) Product Market Performance
10.8.4 Biogйnesis-Bago Business Overview
10.8.5 Biogйnesis-Bago Recent Developments
10.9 CAVAC
10.9.1 CAVAC Biothrax (Anthrax Vaccine) Basic Information
10.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Overview
10.9.3 CAVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.9.4 CAVAC Business Overview
10.9.5 CAVAC Recent Developments
10.10 Rosenbusch
10.10.1 Rosenbusch Biothrax (Anthrax Vaccine) Basic Information
10.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
10.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Product Market Performance
10.10.4 Rosenbusch Business Overview
10.10.5 Rosenbusch Recent Developments
10.11 Agrovet
10.11.1 Agrovet Biothrax (Anthrax Vaccine) Basic Information
10.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Overview
10.11.3 Agrovet Biothrax (Anthrax Vaccine) Product Market Performance
10.11.4 Agrovet Business Overview
10.11.5 Agrovet Recent Developments
10.12 Vecol
10.12.1 Vecol Biothrax (Anthrax Vaccine) Basic Information
10.12.2 Vecol Biothrax (Anthrax Vaccine) Product Overview
10.12.3 Vecol Biothrax (Anthrax Vaccine) Product Market Performance
10.12.4 Vecol Business Overview
10.12.5 Vecol Recent Developments
10.13 CVCRI
10.13.1 CVCRI Biothrax (Anthrax Vaccine) Basic Information
10.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Overview
10.13.3 CVCRI Biothrax (Anthrax Vaccine) Product Market Performance
10.13.4 CVCRI Business Overview
10.13.5 CVCRI Recent Developments
10.14 IVPM
10.14.1 IVPM Biothrax (Anthrax Vaccine) Basic Information
10.14.2 IVPM Biothrax (Anthrax Vaccine) Product Overview
10.14.3 IVPM Biothrax (Anthrax Vaccine) Product Market Performance
10.14.4 IVPM Business Overview
10.14.5 IVPM Recent Developments
10.15 Prondil
10.15.1 Prondil Biothrax (Anthrax Vaccine) Basic Information
10.15.2 Prondil Biothrax (Anthrax Vaccine) Product Overview
10.15.3 Prondil Biothrax (Anthrax Vaccine) Product Market Performance
10.15.4 Prondil Business Overview
10.15.5 Prondil Recent Developments
10.16 CDV
10.16.1 CDV Biothrax (Anthrax Vaccine) Basic Information
10.16.2 CDV Biothrax (Anthrax Vaccine) Product Overview
10.16.3 CDV Biothrax (Anthrax Vaccine) Product Market Performance
10.16.4 CDV Business Overview
10.16.5 CDV Recent Developments
10.17 Indian Immunologicals
10.17.1 Indian Immunologicals Biothrax (Anthrax Vaccine) Basic Information
10.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
10.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Market Performance
10.17.4 Indian Immunologicals Business Overview
10.17.5 Indian Immunologicals Recent Developments
10.18 Botswana Vaccine Institute
10.18.1 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Basic Information
10.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
10.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Market Performance
10.18.4 Botswana Vaccine Institute Business Overview
10.18.5 Botswana Vaccine Institute Recent Developments
10.19 Ceva Santй Animale
10.19.1 Ceva Santй Animale Biothrax (Anthrax Vaccine) Basic Information
10.19.2 Ceva Santй Animale Biothrax (Anthrax Vaccine) Product Overview
10.19.3 Ceva Santй Animale Biothrax (Anthrax Vaccine) Product Market Performance
10.19.4 Ceva Santй Animale Business Overview
10.19.5 Ceva Santй Animale Recent Developments
10.20 Intervac
10.20.1 Intervac Biothrax (Anthrax Vaccine) Basic Information
10.20.2 Intervac Biothrax (Anthrax Vaccine) Product Overview
10.20.3 Intervac Biothrax (Anthrax Vaccine) Product Market Performance
10.20.4 Intervac Business Overview
10.20.5 Intervac Recent Developments
10.21 JOVAC
10.21.1 JOVAC Biothrax (Anthrax Vaccine) Basic Information
10.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Overview
10.21.3 JOVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.21.4 JOVAC Business Overview
10.21.5 JOVAC Recent Developments
11 BIOTHRAX (ANTHRAX VACCINE) MARKET FORECAST BY REGION
11.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast
11.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.3 Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region
11.2.4 South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Biothrax (Anthrax Vaccine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Biothrax (Anthrax Vaccine) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Type (2025-2032)
12.1.2 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Biothrax (Anthrax Vaccine) by Type (2025-2032)
12.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Application (2025-2032)
12.2.1 Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application
12.2.2 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biothrax (Anthrax Vaccine)
1.2 Key Market Segments
1.2.1 Biothrax (Anthrax Vaccine) Segment by Type
1.2.2 Biothrax (Anthrax Vaccine) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOTHRAX (ANTHRAX VACCINE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOTHRAX (ANTHRAX VACCINE) MARKET COMPETITIVE LANDSCAPE
3.1 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (2019-2024)
3.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2019-2024)
3.3 Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biothrax (Anthrax Vaccine) Sales Sites, Area Served, Product Type
3.6 Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
3.6.1 Biothrax (Anthrax Vaccine) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOTHRAX (ANTHRAX VACCINE) INDUSTRY CHAIN ANALYSIS
4.1 Biothrax (Anthrax Vaccine) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOTHRAX (ANTHRAX VACCINE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2019-2024)
6.3 Global Biothrax (Anthrax Vaccine) Market Size Market Share by Type (2019-2024)
6.4 Global Biothrax (Anthrax Vaccine) Price by Type (2019-2024)
7 BIOTHRAX (ANTHRAX VACCINE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biothrax (Anthrax Vaccine) Market Sales by Application (2019-2024)
7.3 Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Application (2019-2024)
7.4 Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2019-2024)
8 BIOTHRAX (ANTHRAX VACCINE) MARKET CONSUMPTION BY REGION
8.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.1 Global Biothrax (Anthrax Vaccine) Sales by Region
8.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Region
8.2 North America
8.2.1 North America Biothrax (Anthrax Vaccine) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biothrax (Anthrax Vaccine) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biothrax (Anthrax Vaccine) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 BIOTHRAX (ANTHRAX VACCINE) MARKET PRODUCTION BY REGION
9.1 Global Production of Biothrax (Anthrax Vaccine) by Region (2019-2024)
9.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2019-2024)
9.3 Global Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Biothrax (Anthrax Vaccine) Production
9.4.1 North America Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.4.2 North America Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Biothrax (Anthrax Vaccine) Production
9.5.1 Europe Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.5.2 Europe Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Biothrax (Anthrax Vaccine) Production (2019-2024)
9.6.1 Japan Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.6.2 Japan Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Biothrax (Anthrax Vaccine) Production (2019-2024)
9.7.1 China Biothrax (Anthrax Vaccine) Production Growth Rate (2019-2024)
9.7.2 China Biothrax (Anthrax Vaccine) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Merial
10.1.1 Merial Biothrax (Anthrax Vaccine) Basic Information
10.1.2 Merial Biothrax (Anthrax Vaccine) Product Overview
10.1.3 Merial Biothrax (Anthrax Vaccine) Product Market Performance
10.1.4 Merial Business Overview
10.1.5 Merial Biothrax (Anthrax Vaccine) SWOT Analysis
10.1.6 Merial Recent Developments
10.2 Merck
10.2.1 Merck Biothrax (Anthrax Vaccine) Basic Information
10.2.2 Merck Biothrax (Anthrax Vaccine) Product Overview
10.2.3 Merck Biothrax (Anthrax Vaccine) Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck Biothrax (Anthrax Vaccine) SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Zoetis
10.3.1 Zoetis Biothrax (Anthrax Vaccine) Basic Information
10.3.2 Zoetis Biothrax (Anthrax Vaccine) Product Overview
10.3.3 Zoetis Biothrax (Anthrax Vaccine) Product Market Performance
10.3.4 Zoetis Biothrax (Anthrax Vaccine) SWOT Analysis
10.3.5 Zoetis Business Overview
10.3.6 Zoetis Recent Developments
10.4 Bayer Sanidad Animal
10.4.1 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Basic Information
10.4.2 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
10.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Market Performance
10.4.4 Bayer Sanidad Animal Business Overview
10.4.5 Bayer Sanidad Animal Recent Developments
10.5 Colorado Serum
10.5.1 Colorado Serum Biothrax (Anthrax Vaccine) Basic Information
10.5.2 Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
10.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Product Market Performance
10.5.4 Colorado Serum Business Overview
10.5.5 Colorado Serum Recent Developments
10.6 PharmAthene
10.6.1 PharmAthene Biothrax (Anthrax Vaccine) Basic Information
10.6.2 PharmAthene Biothrax (Anthrax Vaccine) Product Overview
10.6.3 PharmAthene Biothrax (Anthrax Vaccine) Product Market Performance
10.6.4 PharmAthene Business Overview
10.6.5 PharmAthene Recent Developments
10.7 Tiankang
10.7.1 Tiankang Biothrax (Anthrax Vaccine) Basic Information
10.7.2 Tiankang Biothrax (Anthrax Vaccine) Product Overview
10.7.3 Tiankang Biothrax (Anthrax Vaccine) Product Market Performance
10.7.4 Tiankang Business Overview
10.7.5 Tiankang Recent Developments
10.8 Biogйnesis-Bago
10.8.1 Biogйnesis-Bago Biothrax (Anthrax Vaccine) Basic Information
10.8.2 Biogйnesis-Bago Biothrax (Anthrax Vaccine) Product Overview
10.8.3 Biogйnesis-Bago Biothrax (Anthrax Vaccine) Product Market Performance
10.8.4 Biogйnesis-Bago Business Overview
10.8.5 Biogйnesis-Bago Recent Developments
10.9 CAVAC
10.9.1 CAVAC Biothrax (Anthrax Vaccine) Basic Information
10.9.2 CAVAC Biothrax (Anthrax Vaccine) Product Overview
10.9.3 CAVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.9.4 CAVAC Business Overview
10.9.5 CAVAC Recent Developments
10.10 Rosenbusch
10.10.1 Rosenbusch Biothrax (Anthrax Vaccine) Basic Information
10.10.2 Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
10.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Product Market Performance
10.10.4 Rosenbusch Business Overview
10.10.5 Rosenbusch Recent Developments
10.11 Agrovet
10.11.1 Agrovet Biothrax (Anthrax Vaccine) Basic Information
10.11.2 Agrovet Biothrax (Anthrax Vaccine) Product Overview
10.11.3 Agrovet Biothrax (Anthrax Vaccine) Product Market Performance
10.11.4 Agrovet Business Overview
10.11.5 Agrovet Recent Developments
10.12 Vecol
10.12.1 Vecol Biothrax (Anthrax Vaccine) Basic Information
10.12.2 Vecol Biothrax (Anthrax Vaccine) Product Overview
10.12.3 Vecol Biothrax (Anthrax Vaccine) Product Market Performance
10.12.4 Vecol Business Overview
10.12.5 Vecol Recent Developments
10.13 CVCRI
10.13.1 CVCRI Biothrax (Anthrax Vaccine) Basic Information
10.13.2 CVCRI Biothrax (Anthrax Vaccine) Product Overview
10.13.3 CVCRI Biothrax (Anthrax Vaccine) Product Market Performance
10.13.4 CVCRI Business Overview
10.13.5 CVCRI Recent Developments
10.14 IVPM
10.14.1 IVPM Biothrax (Anthrax Vaccine) Basic Information
10.14.2 IVPM Biothrax (Anthrax Vaccine) Product Overview
10.14.3 IVPM Biothrax (Anthrax Vaccine) Product Market Performance
10.14.4 IVPM Business Overview
10.14.5 IVPM Recent Developments
10.15 Prondil
10.15.1 Prondil Biothrax (Anthrax Vaccine) Basic Information
10.15.2 Prondil Biothrax (Anthrax Vaccine) Product Overview
10.15.3 Prondil Biothrax (Anthrax Vaccine) Product Market Performance
10.15.4 Prondil Business Overview
10.15.5 Prondil Recent Developments
10.16 CDV
10.16.1 CDV Biothrax (Anthrax Vaccine) Basic Information
10.16.2 CDV Biothrax (Anthrax Vaccine) Product Overview
10.16.3 CDV Biothrax (Anthrax Vaccine) Product Market Performance
10.16.4 CDV Business Overview
10.16.5 CDV Recent Developments
10.17 Indian Immunologicals
10.17.1 Indian Immunologicals Biothrax (Anthrax Vaccine) Basic Information
10.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
10.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Market Performance
10.17.4 Indian Immunologicals Business Overview
10.17.5 Indian Immunologicals Recent Developments
10.18 Botswana Vaccine Institute
10.18.1 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Basic Information
10.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
10.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Market Performance
10.18.4 Botswana Vaccine Institute Business Overview
10.18.5 Botswana Vaccine Institute Recent Developments
10.19 Ceva Santй Animale
10.19.1 Ceva Santй Animale Biothrax (Anthrax Vaccine) Basic Information
10.19.2 Ceva Santй Animale Biothrax (Anthrax Vaccine) Product Overview
10.19.3 Ceva Santй Animale Biothrax (Anthrax Vaccine) Product Market Performance
10.19.4 Ceva Santй Animale Business Overview
10.19.5 Ceva Santй Animale Recent Developments
10.20 Intervac
10.20.1 Intervac Biothrax (Anthrax Vaccine) Basic Information
10.20.2 Intervac Biothrax (Anthrax Vaccine) Product Overview
10.20.3 Intervac Biothrax (Anthrax Vaccine) Product Market Performance
10.20.4 Intervac Business Overview
10.20.5 Intervac Recent Developments
10.21 JOVAC
10.21.1 JOVAC Biothrax (Anthrax Vaccine) Basic Information
10.21.2 JOVAC Biothrax (Anthrax Vaccine) Product Overview
10.21.3 JOVAC Biothrax (Anthrax Vaccine) Product Market Performance
10.21.4 JOVAC Business Overview
10.21.5 JOVAC Recent Developments
11 BIOTHRAX (ANTHRAX VACCINE) MARKET FORECAST BY REGION
11.1 Global Biothrax (Anthrax Vaccine) Market Size Forecast
11.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.3 Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region
11.2.4 South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Biothrax (Anthrax Vaccine) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Biothrax (Anthrax Vaccine) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Type (2025-2032)
12.1.2 Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Biothrax (Anthrax Vaccine) by Type (2025-2032)
12.2 Global Biothrax (Anthrax Vaccine) Market Forecast by Application (2025-2032)
12.2.1 Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application
12.2.2 Global Biothrax (Anthrax Vaccine) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biothrax (Anthrax Vaccine) Market Size Comparison by Region (M USD)
Table 5. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2022)
Table 10. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biothrax (Anthrax Vaccine) Sales Sites and Area Served
Table 12. Manufacturers Biothrax (Anthrax Vaccine) Product Type
Table 13. Global Biothrax (Anthrax Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biothrax (Anthrax Vaccine)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biothrax (Anthrax Vaccine) Market Challenges
Table 22. Global Biothrax (Anthrax Vaccine) Sales by Type (K MT)
Table 23. Global Biothrax (Anthrax Vaccine) Market Size by Type (M USD)
Table 24. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Type (2019-2024)
Table 25. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2019-2024)
Table 26. Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Type (2019-2024)
Table 27. Global Biothrax (Anthrax Vaccine) Market Size Share by Type (2019-2024)
Table 28. Global Biothrax (Anthrax Vaccine) Price (USD/MT) by Type (2019-2024)
Table 29. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Application
Table 30. Global Biothrax (Anthrax Vaccine) Market Size by Application
Table 31. Global Biothrax (Anthrax Vaccine) Sales by Application (2019-2024) & (K MT)
Table 32. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2019-2024)
Table 33. Global Biothrax (Anthrax Vaccine) Sales by Application (2019-2024) & (M USD)
Table 34. Global Biothrax (Anthrax Vaccine) Market Share by Application (2019-2024)
Table 35. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2019-2024)
Table 36. Global Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K MT)
Table 37. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2019-2024)
Table 38. North America Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K MT)
Table 39. Europe Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K MT)
Table 41. South America Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K MT)
Table 43. Global Biothrax (Anthrax Vaccine) Production (K MT) by Region (2019-2024)
Table 44. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2019-2024)
Table 46. Global Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merial Biothrax (Anthrax Vaccine) Basic Information
Table 52. Merial Biothrax (Anthrax Vaccine) Product Overview
Table 53. Merial Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merial Business Overview
Table 55. Merial Biothrax (Anthrax Vaccine) SWOT Analysis
Table 56. Merial Recent Developments
Table 57. Merck Biothrax (Anthrax Vaccine) Basic Information
Table 58. Merck Biothrax (Anthrax Vaccine) Product Overview
Table 59. Merck Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Merck Business Overview
Table 61. Merck Biothrax (Anthrax Vaccine) SWOT Analysis
Table 62. Merck Recent Developments
Table 63. Zoetis Biothrax (Anthrax Vaccine) Basic Information
Table 64. Zoetis Biothrax (Anthrax Vaccine) Product Overview
Table 65. Zoetis Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Zoetis Biothrax (Anthrax Vaccine) SWOT Analysis
Table 67. Zoetis Business Overview
Table 68. Zoetis Recent Developments
Table 69. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Basic Information
Table 70. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
Table 71. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Bayer Sanidad Animal Business Overview
Table 73. Bayer Sanidad Animal Recent Developments
Table 74. Colorado Serum Biothrax (Anthrax Vaccine) Basic Information
Table 75. Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
Table 76. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Colorado Serum Business Overview
Table 78. Colorado Serum Recent Developments
Table 79. PharmAthene Biothrax (Anthrax Vaccine) Basic Information
Table 80. PharmAthene Biothrax (Anthrax Vaccine) Product Overview
Table 81. PharmAthene Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. PharmAthene Business Overview
Table 83. PharmAthene Recent Developments
Table 84. Tiankang Biothrax (Anthrax Vaccine) Basic Information
Table 85. Tiankang Biothrax (Anthrax Vaccine) Product Overview
Table 86. Tiankang Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Tiankang Business Overview
Table 88. Tiankang Recent Developments
Table 89. Biogйnesis-Bago Biothrax (Anthrax Vaccine) Basic Information
Table 90. Biogйnesis-Bago Biothrax (Anthrax Vaccine) Product Overview
Table 91. Biogйnesis-Bago Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Biogйnesis-Bago Business Overview
Table 93. Biogйnesis-Bago Recent Developments
Table 94. CAVAC Biothrax (Anthrax Vaccine) Basic Information
Table 95. CAVAC Biothrax (Anthrax Vaccine) Product Overview
Table 96. CAVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. CAVAC Business Overview
Table 98. CAVAC Recent Developments
Table 99. Rosenbusch Biothrax (Anthrax Vaccine) Basic Information
Table 100. Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
Table 101. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Rosenbusch Business Overview
Table 103. Rosenbusch Recent Developments
Table 104. Agrovet Biothrax (Anthrax Vaccine) Basic Information
Table 105. Agrovet Biothrax (Anthrax Vaccine) Product Overview
Table 106. Agrovet Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Agrovet Business Overview
Table 108. Agrovet Recent Developments
Table 109. Vecol Biothrax (Anthrax Vaccine) Basic Information
Table 110. Vecol Biothrax (Anthrax Vaccine) Product Overview
Table 111. Vecol Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Vecol Business Overview
Table 113. Vecol Recent Developments
Table 114. CVCRI Biothrax (Anthrax Vaccine) Basic Information
Table 115. CVCRI Biothrax (Anthrax Vaccine) Product Overview
Table 116. CVCRI Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. CVCRI Business Overview
Table 118. CVCRI Recent Developments
Table 119. IVPM Biothrax (Anthrax Vaccine) Basic Information
Table 120. IVPM Biothrax (Anthrax Vaccine) Product Overview
Table 121. IVPM Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. IVPM Business Overview
Table 123. IVPM Recent Developments
Table 124. Prondil Biothrax (Anthrax Vaccine) Basic Information
Table 125. Prondil Biothrax (Anthrax Vaccine) Product Overview
Table 126. Prondil Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Prondil Business Overview
Table 128. Prondil Recent Developments
Table 129. CDV Biothrax (Anthrax Vaccine) Basic Information
Table 130. CDV Biothrax (Anthrax Vaccine) Product Overview
Table 131. CDV Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. CDV Business Overview
Table 133. CDV Recent Developments
Table 134. Indian Immunologicals Biothrax (Anthrax Vaccine) Basic Information
Table 135. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
Table 136. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Indian Immunologicals Business Overview
Table 138. Indian Immunologicals Recent Developments
Table 139. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Basic Information
Table 140. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
Table 141. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Botswana Vaccine Institute Business Overview
Table 143. Botswana Vaccine Institute Recent Developments
Table 144. Ceva Santй Animale Biothrax (Anthrax Vaccine) Basic Information
Table 145. Ceva Santй Animale Biothrax (Anthrax Vaccine) Product Overview
Table 146. Ceva Santй Animale Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Ceva Santй Animale Business Overview
Table 148. Ceva Santй Animale Recent Developments
Table 149. Intervac Biothrax (Anthrax Vaccine) Basic Information
Table 150. Intervac Biothrax (Anthrax Vaccine) Product Overview
Table 151. Intervac Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Intervac Business Overview
Table 153. Intervac Recent Developments
Table 154. JOVAC Biothrax (Anthrax Vaccine) Basic Information
Table 155. JOVAC Biothrax (Anthrax Vaccine) Product Overview
Table 156. JOVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. JOVAC Business Overview
Table 158. JOVAC Recent Developments
Table 159. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2025-2032) & (K MT)
Table 160. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2025-2032) & (M USD)
Table 161. North America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2025-2032) & (K MT)
Table 162. North America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 163. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2025-2032) & (K MT)
Table 164. Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 165. Asia Pacific Biothrax (Anthrax Vaccine) Sales Forecast by Region (2025-2032) & (K MT)
Table 166. Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2025-2032) & (M USD)
Table 167. South America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2025-2032) & (K MT)
Table 168. South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 169. Middle East and Africa Biothrax (Anthrax Vaccine) Consumption Forecast by Country (2025-2032) & (Units)
Table 170. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 171. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2025-2032) & (K MT)
Table 172. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2025-2032) & (M USD)
Table 173. Global Biothrax (Anthrax Vaccine) Price Forecast by Type (2025-2032) & (USD/MT)
Table 174. Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application (2025-2032)
Table 175. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biothrax (Anthrax Vaccine) Market Size Comparison by Region (M USD)
Table 5. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2022)
Table 10. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biothrax (Anthrax Vaccine) Sales Sites and Area Served
Table 12. Manufacturers Biothrax (Anthrax Vaccine) Product Type
Table 13. Global Biothrax (Anthrax Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biothrax (Anthrax Vaccine)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biothrax (Anthrax Vaccine) Market Challenges
Table 22. Global Biothrax (Anthrax Vaccine) Sales by Type (K MT)
Table 23. Global Biothrax (Anthrax Vaccine) Market Size by Type (M USD)
Table 24. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Type (2019-2024)
Table 25. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2019-2024)
Table 26. Global Biothrax (Anthrax Vaccine) Market Size (M USD) by Type (2019-2024)
Table 27. Global Biothrax (Anthrax Vaccine) Market Size Share by Type (2019-2024)
Table 28. Global Biothrax (Anthrax Vaccine) Price (USD/MT) by Type (2019-2024)
Table 29. Global Biothrax (Anthrax Vaccine) Sales (K MT) by Application
Table 30. Global Biothrax (Anthrax Vaccine) Market Size by Application
Table 31. Global Biothrax (Anthrax Vaccine) Sales by Application (2019-2024) & (K MT)
Table 32. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2019-2024)
Table 33. Global Biothrax (Anthrax Vaccine) Sales by Application (2019-2024) & (M USD)
Table 34. Global Biothrax (Anthrax Vaccine) Market Share by Application (2019-2024)
Table 35. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2019-2024)
Table 36. Global Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K MT)
Table 37. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2019-2024)
Table 38. North America Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K MT)
Table 39. Europe Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K MT)
Table 41. South America Biothrax (Anthrax Vaccine) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Region (2019-2024) & (K MT)
Table 43. Global Biothrax (Anthrax Vaccine) Production (K MT) by Region (2019-2024)
Table 44. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2019-2024)
Table 46. Global Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Biothrax (Anthrax Vaccine) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merial Biothrax (Anthrax Vaccine) Basic Information
Table 52. Merial Biothrax (Anthrax Vaccine) Product Overview
Table 53. Merial Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merial Business Overview
Table 55. Merial Biothrax (Anthrax Vaccine) SWOT Analysis
Table 56. Merial Recent Developments
Table 57. Merck Biothrax (Anthrax Vaccine) Basic Information
Table 58. Merck Biothrax (Anthrax Vaccine) Product Overview
Table 59. Merck Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Merck Business Overview
Table 61. Merck Biothrax (Anthrax Vaccine) SWOT Analysis
Table 62. Merck Recent Developments
Table 63. Zoetis Biothrax (Anthrax Vaccine) Basic Information
Table 64. Zoetis Biothrax (Anthrax Vaccine) Product Overview
Table 65. Zoetis Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Zoetis Biothrax (Anthrax Vaccine) SWOT Analysis
Table 67. Zoetis Business Overview
Table 68. Zoetis Recent Developments
Table 69. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Basic Information
Table 70. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Overview
Table 71. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Bayer Sanidad Animal Business Overview
Table 73. Bayer Sanidad Animal Recent Developments
Table 74. Colorado Serum Biothrax (Anthrax Vaccine) Basic Information
Table 75. Colorado Serum Biothrax (Anthrax Vaccine) Product Overview
Table 76. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Colorado Serum Business Overview
Table 78. Colorado Serum Recent Developments
Table 79. PharmAthene Biothrax (Anthrax Vaccine) Basic Information
Table 80. PharmAthene Biothrax (Anthrax Vaccine) Product Overview
Table 81. PharmAthene Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. PharmAthene Business Overview
Table 83. PharmAthene Recent Developments
Table 84. Tiankang Biothrax (Anthrax Vaccine) Basic Information
Table 85. Tiankang Biothrax (Anthrax Vaccine) Product Overview
Table 86. Tiankang Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Tiankang Business Overview
Table 88. Tiankang Recent Developments
Table 89. Biogйnesis-Bago Biothrax (Anthrax Vaccine) Basic Information
Table 90. Biogйnesis-Bago Biothrax (Anthrax Vaccine) Product Overview
Table 91. Biogйnesis-Bago Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Biogйnesis-Bago Business Overview
Table 93. Biogйnesis-Bago Recent Developments
Table 94. CAVAC Biothrax (Anthrax Vaccine) Basic Information
Table 95. CAVAC Biothrax (Anthrax Vaccine) Product Overview
Table 96. CAVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. CAVAC Business Overview
Table 98. CAVAC Recent Developments
Table 99. Rosenbusch Biothrax (Anthrax Vaccine) Basic Information
Table 100. Rosenbusch Biothrax (Anthrax Vaccine) Product Overview
Table 101. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Rosenbusch Business Overview
Table 103. Rosenbusch Recent Developments
Table 104. Agrovet Biothrax (Anthrax Vaccine) Basic Information
Table 105. Agrovet Biothrax (Anthrax Vaccine) Product Overview
Table 106. Agrovet Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Agrovet Business Overview
Table 108. Agrovet Recent Developments
Table 109. Vecol Biothrax (Anthrax Vaccine) Basic Information
Table 110. Vecol Biothrax (Anthrax Vaccine) Product Overview
Table 111. Vecol Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Vecol Business Overview
Table 113. Vecol Recent Developments
Table 114. CVCRI Biothrax (Anthrax Vaccine) Basic Information
Table 115. CVCRI Biothrax (Anthrax Vaccine) Product Overview
Table 116. CVCRI Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. CVCRI Business Overview
Table 118. CVCRI Recent Developments
Table 119. IVPM Biothrax (Anthrax Vaccine) Basic Information
Table 120. IVPM Biothrax (Anthrax Vaccine) Product Overview
Table 121. IVPM Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. IVPM Business Overview
Table 123. IVPM Recent Developments
Table 124. Prondil Biothrax (Anthrax Vaccine) Basic Information
Table 125. Prondil Biothrax (Anthrax Vaccine) Product Overview
Table 126. Prondil Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Prondil Business Overview
Table 128. Prondil Recent Developments
Table 129. CDV Biothrax (Anthrax Vaccine) Basic Information
Table 130. CDV Biothrax (Anthrax Vaccine) Product Overview
Table 131. CDV Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. CDV Business Overview
Table 133. CDV Recent Developments
Table 134. Indian Immunologicals Biothrax (Anthrax Vaccine) Basic Information
Table 135. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Overview
Table 136. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Indian Immunologicals Business Overview
Table 138. Indian Immunologicals Recent Developments
Table 139. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Basic Information
Table 140. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Overview
Table 141. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Botswana Vaccine Institute Business Overview
Table 143. Botswana Vaccine Institute Recent Developments
Table 144. Ceva Santй Animale Biothrax (Anthrax Vaccine) Basic Information
Table 145. Ceva Santй Animale Biothrax (Anthrax Vaccine) Product Overview
Table 146. Ceva Santй Animale Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Ceva Santй Animale Business Overview
Table 148. Ceva Santй Animale Recent Developments
Table 149. Intervac Biothrax (Anthrax Vaccine) Basic Information
Table 150. Intervac Biothrax (Anthrax Vaccine) Product Overview
Table 151. Intervac Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Intervac Business Overview
Table 153. Intervac Recent Developments
Table 154. JOVAC Biothrax (Anthrax Vaccine) Basic Information
Table 155. JOVAC Biothrax (Anthrax Vaccine) Product Overview
Table 156. JOVAC Biothrax (Anthrax Vaccine) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. JOVAC Business Overview
Table 158. JOVAC Recent Developments
Table 159. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2025-2032) & (K MT)
Table 160. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2025-2032) & (M USD)
Table 161. North America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2025-2032) & (K MT)
Table 162. North America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 163. Europe Biothrax (Anthrax Vaccine) Sales Forecast by Country (2025-2032) & (K MT)
Table 164. Europe Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 165. Asia Pacific Biothrax (Anthrax Vaccine) Sales Forecast by Region (2025-2032) & (K MT)
Table 166. Asia Pacific Biothrax (Anthrax Vaccine) Market Size Forecast by Region (2025-2032) & (M USD)
Table 167. South America Biothrax (Anthrax Vaccine) Sales Forecast by Country (2025-2032) & (K MT)
Table 168. South America Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 169. Middle East and Africa Biothrax (Anthrax Vaccine) Consumption Forecast by Country (2025-2032) & (Units)
Table 170. Middle East and Africa Biothrax (Anthrax Vaccine) Market Size Forecast by Country (2025-2032) & (M USD)
Table 171. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2025-2032) & (K MT)
Table 172. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Type (2025-2032) & (M USD)
Table 173. Global Biothrax (Anthrax Vaccine) Price Forecast by Type (2025-2032) & (USD/MT)
Table 174. Global Biothrax (Anthrax Vaccine) Sales (K MT) Forecast by Application (2025-2032)
Table 175. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biothrax (Anthrax Vaccine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biothrax (Anthrax Vaccine) Market Size (M USD), 2019-2032
Figure 5. Global Biothrax (Anthrax Vaccine) Market Size (M USD) (2019-2032)
Figure 6. Global Biothrax (Anthrax Vaccine) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biothrax (Anthrax Vaccine) Market Size by Country (M USD)
Figure 11. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2023
Figure 12. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2023
Figure 13. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biothrax (Anthrax Vaccine) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biothrax (Anthrax Vaccine) Market Share by Type
Figure 18. Sales Market Share of Biothrax (Anthrax Vaccine) by Type (2019-2024)
Figure 19. Sales Market Share of Biothrax (Anthrax Vaccine) by Type in 2023
Figure 20. Market Size Share of Biothrax (Anthrax Vaccine) by Type (2019-2024)
Figure 21. Market Size Market Share of Biothrax (Anthrax Vaccine) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biothrax (Anthrax Vaccine) Market Share by Application
Figure 24. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2019-2024)
Figure 25. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application in 2023
Figure 26. Global Biothrax (Anthrax Vaccine) Market Share by Application (2019-2024)
Figure 27. Global Biothrax (Anthrax Vaccine) Market Share by Application in 2023
Figure 28. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2019-2024)
Figure 30. North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2023
Figure 32. U.S. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Biothrax (Anthrax Vaccine) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Biothrax (Anthrax Vaccine) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2023
Figure 37. Germany Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2023
Figure 44. China Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 50. South America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2023
Figure 51. Brazil Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Biothrax (Anthrax Vaccine) Production Market Share by Region (2019-2024)
Figure 62. North America Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 65. China Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Biothrax (Anthrax Vaccine) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Type (2025-2032)
Figure 70. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2025-2032)
Figure 71. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Biothrax (Anthrax Vaccine)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biothrax (Anthrax Vaccine) Market Size (M USD), 2019-2032
Figure 5. Global Biothrax (Anthrax Vaccine) Market Size (M USD) (2019-2032)
Figure 6. Global Biothrax (Anthrax Vaccine) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biothrax (Anthrax Vaccine) Market Size by Country (M USD)
Figure 11. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2023
Figure 12. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2023
Figure 13. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biothrax (Anthrax Vaccine) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biothrax (Anthrax Vaccine) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biothrax (Anthrax Vaccine) Market Share by Type
Figure 18. Sales Market Share of Biothrax (Anthrax Vaccine) by Type (2019-2024)
Figure 19. Sales Market Share of Biothrax (Anthrax Vaccine) by Type in 2023
Figure 20. Market Size Share of Biothrax (Anthrax Vaccine) by Type (2019-2024)
Figure 21. Market Size Market Share of Biothrax (Anthrax Vaccine) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biothrax (Anthrax Vaccine) Market Share by Application
Figure 24. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2019-2024)
Figure 25. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application in 2023
Figure 26. Global Biothrax (Anthrax Vaccine) Market Share by Application (2019-2024)
Figure 27. Global Biothrax (Anthrax Vaccine) Market Share by Application in 2023
Figure 28. Global Biothrax (Anthrax Vaccine) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2019-2024)
Figure 30. North America Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2023
Figure 32. U.S. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Biothrax (Anthrax Vaccine) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Biothrax (Anthrax Vaccine) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2023
Figure 37. Germany Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2023
Figure 44. China Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 50. South America Biothrax (Anthrax Vaccine) Sales Market Share by Country in 2023
Figure 51. Brazil Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Biothrax (Anthrax Vaccine) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Biothrax (Anthrax Vaccine) Production Market Share by Region (2019-2024)
Figure 62. North America Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 65. China Biothrax (Anthrax Vaccine) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Biothrax (Anthrax Vaccine) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Biothrax (Anthrax Vaccine) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Type (2025-2032)
Figure 70. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2025-2032)
Figure 71. Global Biothrax (Anthrax Vaccine) Market Share Forecast by Application (2025-2032)
